The landscape of dementia diagnosis has evolved substantially with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly exams that will detect Alzheimer's pathology a long time prior to signs and symptoms arise. When these technological advancements depict impressive progress in knowing neurodegenerative illnesses, https://terryy086alw7.wikicorrespondence.com/user